The Joint Corp.
JYNT · Price history
Price at last available close
$7.22
−$0.88 (-10.86%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About The Joint Corp.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
The Joint Corp. specializes in the establishment, proprietorship, operation, and overall administration of chiropractic treatment centers. Its business operations are structured into two main divisions: corporate-owned clinics and franchised facilities. The firm employs several strategic models for its expansion and day-to-day functioning, which include direct company ownership, various management agreements, licensing its brand to franchisees, and collaborating with regional development partners.
How they make money
The Joint Corp. operates as a franchisor and operator of chiropractic clinics. It generates revenue primarily through franchise fees, royalties, and advertising contributions from franchisees, as well as through direct management and operation of corporate-owned clinics.
Products & services
The company provides routine and affordable chiropractic care through its retail-based network, The Joint Chiropractic, offering various wellness plans and individual visit options.
Brands & revenue mix
The primary brand under which the company operates its network of chiropractic clinics.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Period ended 2025-12-31Source
Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
No quantified customer-concentration disclosure is available in the current saved research.
Suppliers, materials & equipment
- unnamed — The company relies on various third-party vendors for clinic equipment, software systems, and marketing services.Source
Strengths
- Nation's largest operator, manager and franchisor of chiropractic clinicsSource
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
35
Poor
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
56
Fair
Financial Strength
68
Business Quality / Moat
32
Management
100
Growth Quality
31
Risk / Durability
30
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
42
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
50/100
Building Historical Record
Model Score 50/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
- •Insider activity signal is favorable
- •Recent buyback activity is present
- •Valuation is a weaker part of the current profile
- •Revenue fundamentals are weak
- •Asset quality is a weaker factor
Company-specific research
Questions worth answering for JYNT
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can JYNT maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is JYNT's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •How is JYNT likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What future growth or profitability would be needed to justify JYNT's current valuation?
Essential Investment Snapshot
Wall Street Score
35
Opportunity Score
42
Market Cap
$102.0M
P/E Ratio
28.2
EPS
$0.27
52-Week High
$10.67
52-Week Low
$7.25
Beta
1.06
Intrinsic Value
$2.26
Analyst Target
$20.00
Shares Outstanding
15.1M
Total Revenue
$58.5M
Total Debt
$2.0M
Dividend
No current dividend
Liquidation Value / Share
$1.05
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Low movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for JYNT
Detected from reported data — verify before acting.Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on JYNT.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Nation's largest operator, manager and franchisor of chiropractic clinics.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
- −Dependence on the success of franchisees and their ability to operate clinics effectively.
- −Regulatory risks associated with the practice of chiropractic and healthcare management.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
2 historical score records availablePrevious Score
33
Jul 24, 2026
Change
+2.3
points
Current Score
35
Oct 1, 2026
Category Changes
JYNT increased 2.3 points because Revenue improved by 5.4 points, Capital improved by 6 points, Valuation improved by 12.4 points.
Positive Contributors
- + Revenue improved by 5.4 points
- + Capital improved by 6 points
- + Valuation improved by 12.4 points
- + Buffett improved by 2.3 points
Projected Score
Projected Score
41
Projected Change
+6.0 points
Preliminary comparable-period financial changes suggest improvement of approximately 6.0 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
OvervaluedCurrent Price
$7.21
Model Intrinsic Value
$2.26
Difference
+$4.96
+219.9% vs IV
Margin of Safety
-219.9%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $58.5M | $54.9M | $52.2M | $47.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $11.1M | $11.2M | $11.5M | $10.5M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $47.5M | $43.7M | $40.6M | $36.5M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $44.3M | $42.9M | $41.1M | $34.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $46.0M | $44.6M | $42.5M | $36.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $3.8M | $1.5M | $2.9M | $8.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $1.4M | -$905K | -$1.9M | $318K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $0.00 | $0.00 | $0.00 | $64K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $2.1M | -$230K | -$1.6M | $254K | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $34K | $39K | $6K | $11.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $3.8M | $2.9M | -$5.8M | -$9.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $0.27 | $0.19 | $-0.39 | $-0.66 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 14.24M | 15.13M | 14.92M | 14.69M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 14.25M | 15.13M | 15.15M | 14.69M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$15.2M
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.05
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
-6.2%
Cash Change
-25.7%
Margin Change
+3.6 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Debt reduced
What Weakened
- Cash position declined
Potential Score Impact
Positive indicators included revenue growth, EPS growth, debt levels, net income margin. Pressure indicators included cash levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 14.4%. EPS increased 719.7%. Cash declined 25.7%. Total debt declined 6.2%. Net income margin improved by 3.6 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
2 historical records2 historical score records available.
Historical Score Chart
2 of 2 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Care FacilitiesNews
49North Signs MOU with UNWAVE for Joint Production and Support of Counter-UAS Systems
E-Power's Guizhou Joint Venture Receives RMB 110 Million of RMB 200 Million Capital Increase at RMB 2.0 Billion Post-Money Valuation
Vornado, Ken Griffin and Rudin Close Joint Venture, 1.05 Million SF Anchor Lease and $3.3 Billion Construction Loan
Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
Rumor Mill · JYNT
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial